These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 30763
41. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study. Hovens JE, Dries PJ, Melman CT, Wapenaar RJ, Loonen AJ. J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129 [Abstract] [Full Text] [Related]
42. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects. Morton S, Lader M. Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277 [Abstract] [Full Text] [Related]
43. Double-blind randomized trial of the benzodiazepine derivative metaclazepam as compared with placebo treatment of outpatients with anxiety syndromes. Laakmann G, Blaschke D, Hippius H, Schewe S. Pharmacopsychiatry; 1988 May; 21(3):136-43. PubMed ID: 2900514 [Abstract] [Full Text] [Related]
44. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study]. Bernardi F, Fossi L, Faravelli C, Corsini GU, Varricchio MC. Riv Patol Nerv Ment; 1984 May; 105(1):1-13. PubMed ID: 6571441 [Abstract] [Full Text] [Related]
45. Evaluation of the safety and therapeutic effects of lorazepam on long-term use. Siassi I, Thomas M, Vanov SK. Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):163-71. PubMed ID: 240649 [No Abstract] [Full Text] [Related]
46. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder. Ballenger JC, McDonald S, Noyes R, Rickels K, Sussman N, Woods S, Patin J, Singer J. Psychopharmacol Bull; 1991 Jul; 27(2):171-9. PubMed ID: 1681563 [Abstract] [Full Text] [Related]
52. [Clinical study of bromazepam. Thirty cases (author's transl)]. Sechter D, Petitjean F, Bitoun G. Nouv Presse Med; 1982 May 13; 11(22):1744-6. PubMed ID: 6124949 [Abstract] [Full Text] [Related]
53. Controlled comparison of bromazepam, amitriptyline, and placebo in anxiety-depressive neurosis. Shammas E. Dis Nerv Syst; 1977 Mar 13; 38(3):201-7. PubMed ID: 13969 [Abstract] [Full Text] [Related]
55. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder. Cohn JB, Wilcox CS. Pharmacotherapy; 1984 Mar 13; 4(2):93-8. PubMed ID: 6144090 [Abstract] [Full Text] [Related]
58. A study in the management of anxiety with lorazepam. Ellison RJ, Cancellaro LA. J Clin Pharmacol; 1978 Apr 13; 18(4):210-9. PubMed ID: 24646 [Abstract] [Full Text] [Related]
59. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Woelk H, Schläfke S. Phytomedicine; 2010 Feb 13; 17(2):94-9. PubMed ID: 19962288 [Abstract] [Full Text] [Related]
60. A comparative study of suriclone, lorazepam and placebo in anxiety disorder. de Jonghe F, Swinkels J, Tuynman-Qua H, Jonkers F. Pharmacopsychiatry; 1989 Nov 13; 22(6):266-71. PubMed ID: 2575766 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]